Kowa Company, Ltd. Securities Report - 120th Period (2025/04/01 - 2026/03/31)

Kowa Company, Ltd. Securities Report - 120th Period (2025/04/01 - 2026/03/31)

Kowa Company, Ltd. has published its 120th securities report. This report details the performance and financial situation from April 1, 2025, to March 31, 2026.

Company Overview Kowa Company, Ltd. is a pharmaceutical company established in 1948, also providing medical devices and healthcare-related services. Our mission is to provide high-quality medical products and services to improve the quality of life for patients.

Financial Situation From April 1, 2025, to March 31, 2026, the company's revenue was 50 billion yen, and net profit was 5 billion yen. During this period, the company achieved significant growth in the fields of medical technology and healthcare solutions.

Strategic Direction The company is focusing on medical technology and healthcare solutions, aiming for growth in the international market. Future prospects include the development and market introduction of new medical technologies.

Market Impact This report suggests the company's future direction and market trends. The demand for medical technology and healthcare solutions is increasing, and the company's growth is expected.

Conclusion Kowa Company, Ltd. continues to innovate in the fields of medical technology and healthcare solutions, aiming for growth in the international market. This report provides important information for understanding the company's financial situation and strategic direction.